Rex Bionics : UK Launch of REX at Neurological Rehab Conference

11 June 2014

Rex Bionics plc

("Rex Bionics" or the "Company")

UK Launch of REX at Major Neurological Rehabilitation Conference

Rex Bionics plc (AIM: RXB), the developer and manufacturer of REX products: hands-free robotic exoskeletons for use by wheelchair users, announces that it will be launching REX into the UK market at the Neurological Rehabilitation Expo 2014 at London's ExCel on 12-13 June.

Neurological Rehabilitation Therapy & Technology 2014 is the UK's largest show for medical professionals working in the rehabilitation of neurological conditions and is expected to be attended by more than 1,500 professionals from around the world. Rex Bionics will be present at its exhibition booth, N604. A BBC film crew will be attending the event to film REX.

"We are extremely excited to be launching REX in the UK at this prestigious event", Jeremy Curnock Cook, Chief Executive Officer of REX Bionics , said. "REX is now gaining a vast amount of publicity driven by demand and interest in the important technology.  This will be a great opportunity for us to demonstrate the benefits of REX first-hand to international experts in the field, and to introduce the members of our new UK sales force."

Following its successful IPO and Admission to AIM in early May, Rex Bionics has recently completed the recruitment of an experienced team of sales professionals to lead the UK launch of REX Rehab, targeted at spinal cord injury rehabilitation centres. Rex Bionics is headquartered in Thame, UK.

For further information please contact:

Rex Bionics Plc

Jeremy Curnock Cook, Chief Executive Officer

+44 (0) 781 086 6386

Peter Worrall, Chief Financial Officer

+44 (0)1428 645416

Oriel Securities Limited (NOMAD and Broker)

Juliet Thompson/Jonathan Senior

+44 (0) 20 7710 7600

Consilium Strategic Communications

Mary-Jane Elliott / Emma Thompson / Jessica Hodgson / Lindsey Neville

rexbionics@consilium-comms.com

+44 (0) 203 709 5700

About Rex Bionics

Rex Bionics (AIM: RXB) is an AIM-listed developer and manufacturer of REX products, hands-free robotic exoskeletons for use by people with mobility impairments. Founded in Auckland, New Zealand by two robotics engineers with first-hand experience of wheelchair users and their needs, Rex Bionics focuses on products designed to enable wheelchair users to stand and walk autonomously without the need for crutches or supports and is the only company to produce hands-free walking devices for wheelchair users. Rex Bionics' marketed products: REX Rehab and REX Personal, can be used by people with complete spinal cord injury, but also by a much broader potential customer base, including people with multiple sclerosis and muscular dystrophy. In May 2014, Rex Bionics joined AIM with a fundraising of £10 million (gross) to scale up production, distribution and marketing internationally, in order to support growing demand for both REX products as well as developing the next generation of REX devices, REX 3.

For more information please visit, www.rexbionics.com